SBOC

What SBOC does

SBOC (Sociedade Brasileira de Oncologia Clínica) is the national professional medical society representing clinical oncologists in Brazil, founded in 1981 and headquartered on Avenida Paulista in São Paulo. The society serves a membership of more than 3,600 clinical oncologists distributed across all 26 Brazilian states and the Federal District, along with oncology residents and other healthcare professionals. Its core mission centers on professional education, clinical research support, treatment guideline development, certification of specialists, and advocacy with the Brazilian Ministry of Health, ANS, and Conitec on oncology drug incorporation and care policy.

SBOC's product portfolio spans a vertically integrated professional ecosystem. Educational offerings include the OncoAcademy platform (courses, videos, podcasts, and programs such as PROC, Board Review, and Fronteiras da Oncologia), the member-exclusive Biblioteca Virtual SBOC with over 1,800 international scientific publications, the SBOC Review publication, and the indexed Brazilian Journal of Oncology (BJO). Clinical guidance is delivered through Diretrizes SBOC (evidence-based treatment guidelines with annual updates), Guias SBOC (practical care guides), and the Índice de Priorização de Medicamentos for drug incorporation prioritization. The society administers three certifications — TEOC (Especialista em Oncologia Clínica), Pediatric Oncology, and Oncogenetics — and runs the Fundo de Incentivo à Pesquisa (FIP) research funding program, the Plataforma de Pesquisa Clínica, and the Clinical Research Training Program in partnership with reference centers such as Hospital de Amor de Barretos.

SBOC operates as a non-profit civil association (associação civil sem fins lucrativos) with revenue generated from individual membership dues (annual, recurring), certification exam fees, educational program fees, and the annual Congress SBOC, which in its 2025 XXVI edition drew over 4,200 attendees from 23 countries with 481 national and 28 international speakers. The society is governed by elected officers and a board, with current president Dra. Clarissa Baldotto (2026 term). Distribution is direct-to-member through the Portal do Associado (assocializa.com.br/sboc), the SBOC mobile app, OncoAcademy, and in-person events. SBOC holds institutional partnerships with ASCO, ESMO, IASLC, MASCC, CACA, OPAS/PAHO, AMB, INCA, Fiocruz/Farmanguinhos, and the Brazilian Ministry of Health, and runs targeted initiatives in women's leadership in oncology, diversity and inclusion (via GBEDIO), and ESG.

Name

SBOC

Legal name

Sociedade Brasileira de Oncologia Clínica

Website

https://sboc.org.br

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

SBOC (Sociedade Brasileira de Oncologia Clínica) is the Brazilian national professional medical society for clinical oncologists, founded in 1981, serving 3,600+ members across all 26 states through education, certification, clinical guidelines, and health policy advocacy.

Ownership category

akta.pro rank

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Fees: Annual membership fees for oncologists, residents, and healthcare professionals. Members receive access to the Portal do Associado, Biblioteca Virtual with 1,800+ publications, OncoAcademy platform, SBOC Review, and other member-exclusive benefits.
2. Educational Programs and Certifications: Revenue from certification exams (TEOC - Especialista em Oncologia Clínica, Pediatric Oncology certification, Oncogenetics certification), training programs, and educational courses through OncoAcademy.
3. Congress and Events: Congress SBOC annual conference and other events generating registration fees, sponsorship, and exhibition revenue. The XXVI Congress Brazilian Oncology Conference had over 4,200 attendees from 23 countries.
4. Publications: Scientific publications including Brazilian Journal of Oncology (BJO) and SBOC Review newsletter.
5. Research Funding (FIP): Fundo de Incentivo à Pesquisa - SBOC financing program for oncology research, funded through partnerships and member contributions.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

SBOC (Sociedade Brasileira de Oncologia Clínica) is a national professional medical society that represents clinical oncologists across Brazil. The society delivers membership-based services including continuing education through the OncoAcademy platform, board certifications (TEOC, Pediatric Oncology, Oncogenetics), access to a digital library of 1,800+ international scientific publications, clinical research funding, treatment guidelines, and the annual Congress SBOC. It also engages in health policy advocacy with the Brazilian Ministry of Health, ANS, and Conitec.

Product overview

SBOC (Sociedade Brasileira de Oncologia Clínica) is the national entity representing clinical oncologists in Brazil since 1981, with over 3,600 members. The organization operates as a unified professional association offering a comprehensive portfolio of products and services for oncology professionals. The core educational offerings include the OncoAcademy platform (educational hub with courses, videos, podcasts, and guides), Biblioteca Virtual (digital library with 1,800+ international scientific publications), SBOC Review (summarized and commented articles), and the Brazilian Journal of Oncology (scientific journal). The organization provides clinical decision support through Diretrizes SBOC (treatment guidelines) and Guias (practical care guides), and maintains the Índice de Priorização de Medicamentos for drug incorporation prioritization. SBOC also offers professional certification programs including TEOC, Pediatric Oncology, and Oncogenetics certifications, runs research funding programs (FIP), clinical research platforms and training programs, and organizes the annual SBOC Congress. Additional initiatives focus on diversity, gender equity, and ESG matters.

Differentiator

Problem solved

Functional benefit

Brands

• OncoAcademy: Educational platform hub offering courses, classes, videos, podcasts, guides, and supplementary documents in oncology and health.
• Escola Brasileira de Oncologia
• Brazilian Journal of Oncology (BJO)
• SBOC Review

Products and services

• OncoAcademy Educational hub platform offering courses, classes, videos, podcasts, guides, and complementary documents in oncology and health for SBOC members.
• Biblioteca Virtual SBOC Digital library with exclusive collection of over 1,800 international scientific publications including ClinicalKey, NEJM, JAMA Oncology, Journal of Clinical Oncology, Nature Reviews Clinical Oncology, and Annals of Oncology, accessible to SBOC members.
• SBOC Review Selected relevant scientific articles, freshly published in the best specialty journals, summarized and commented by SBOC members.
• Brazilian Journal of Oncology (BJO) Scientific journal published by SBOC, indexed in LILACS, featuring research articles in oncology.
• Diretrizes SBOC Therapeutic recommendations based on scientific evidence with annual updates, providing treatment guidelines for oncologists.
• Guias SBOC Orientation materials for health professionals focusing on conduct and practical care in oncology.
• Índice de Priorização de Medicamentos Technical support tool for evaluating incorporation of inputs and technologies for cancer treatment, supporting SUS and supplementary health drug prioritization.
• Exame de Proficiência em Oncologia Clínica (TEOC) Annual certification exam for obtaining the title of Specialist in Clinical Oncology.
• Certificado de Atuação em Oncologia Pediátrica Certification for specialists in pediatric oncology with exam details, timeline, and guidelines.
• Certificado de Atuação em Oncogenética Certification for the area of oncogenetics with exam details, timeline, and guidelines.
• Congresso SBOC Annual Brazilian Congress of Clinical Oncology bringing together oncologists and health professionals for scientific discussions and networking.
• Fundo de Incentivo à Pesquisa (FIP) SBOC financing program for research projects in the oncology field.
• Plataforma de Pesquisa Clínica Platform providing easy access in Portuguese to ongoing clinical studies in Brazil for physicians, patients, and research centers.
• Guia de Cuidados aos Sobreviventes (Guide of Care for Survivors) Guide orienting oncological follow-up management and handling of late sequelae in clinical practice, developed for training primary care physicians in managing cancer survivor care.

Quantifiable outcome

• Over 3,600 associated oncologists nationwide
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered major and core.

• GBEDIO (Grupo Brasileiro de Estudos em Diversidade e Inclusão na Oncologia)majorStrategic or Co-development Partner · 18 June 2026Institutional cooperation agreement motivated by synergy of purposes and interest in contributing to equity promotion and integration of multiple perspectives in the cancer care ecosystem.
• CACA (Chinese Anti-Cancer Association)majorStrategic or Co-development Partner · 2 June 2026Partnership with the Chinese Anti-Cancer Association announced with plans for the first joint event - 2026 China-Brazil Anti Cancer Summit that reached 13 million people.
• IASLC (International Association for the Study of Lung Cancer)coreStrategic or Co-development Partner · 13 April 2026International partnership renewed to strengthen the fight against lung cancer. SBOC collaborates with IASLC on lung cancer research, guidelines, and treatment protocols.
• OPAS/PAHO (Organização Pan-Americana da Saúde)coreStrategic or Co-development Partner · 17 November 2025Memorandum of technical-scientific cooperation signed between SBOC, OPAS, and Ministry of Health during Congress SBOC 2025.
• MASCC (Multinational Association of Supportive Care in Cancer)majorStrategic or Co-development Partner · 15 July 2025Partnership renewal with MASCC, an international organization focused on developing supportive care in cancer. Collaboration on supportive care guidelines and education.
• Fiocruz/FarmanguinhosmajorStrategic or Co-development Partner · 11 June 2025SBOC will advise Farmanguinhos/Fiocruz on a project for an oncology medication manufacturing facility, contributing technical expertise to increase access to cancer treatments.
• ABHH (Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular)majorStrategic or Co-development Partner · 17 April 2025Strategic meeting to plan joint actions in access to treatments, educational programs, and congress participation between SBOC and ABHH.
• ASCO (American Society of Clinical Oncology)coreStrategic or Co-development PartnerInstitutional partnership with the American Society of Clinical Oncology. SBOC maintains collaborative sessions at its annual congress with ASCO, sharing scientific knowledge and best practices in clinical oncology.
• ESMO (European Society for Medical Oncology)coreStrategic or Co-development PartnerInstitutional partnership with the European Society for Medical Oncology. SBOC hosts ESMO Summit Latin America and collaborates on educational content and guidelines.
• AMB (Associação Médica Brasileira)coreStrategic or Co-development PartnerLong-standing partnership with the Brazilian Medical Association. SBOC participates in AMB's Deliberative Council, joint congress sessions, and collaborative publications including the 'Tratado de Medicina Geral'.
• DatafolhamajorStrategic or Co-development PartnerPartnership for research studies including 'Censo da Oncologia Clínica' and 'Pesquisa Liderança Feminina na Oncologia' to understand the profile of oncologists in Brazil.
• Instituto OncoguiamajorStrategic or Co-development PartnerCollaboration on Board of Cancer and Obesity, patient advocacy, and the annual 'Fórum Nacional Oncoguia' discussions on oncology policy.
• GBECAM (Grupo Brasileiro de Estudos em Câncer de Mama)majorStrategic or Co-development PartnerInstitutional partner collaborating on breast cancer research, guidelines, and awareness campaigns.
• Instituto Nacional de Câncer (INCA)coreStrategic or Co-development PartnerParticipation in Consinca (INCA Consultive Council) and collaboration on national cancer control policies and programs.
• Hospital de Amor de BarretosmajorStrategic or Co-development PartnerHospital de Amor de Barretos integrates SBOC's Clinical Research Training Program as a reference center for oncology research training.
• Brazilian Ministry of HealthcoreStrategic or Co-development PartnerTechnical cooperation on oncology health policies, drug incorporation recommendations through Conitec, APAC discussions, and implementation of the National Cancer Prevention and Control Policy.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Associação Médica Brasileira (AMB): AMB is the umbrella national medical association in Brazil. SBOC has a long-standing partnership with AMB, including participation in its Deliberative Council, joint congress sessions, and the Tratado de Medicina Geral. AMB is the structural national counterpart that SBOC operates within.
• Sociedade Brasileira de Cancerologia (SBC): SBC is a Brazilian specialty society for cancerology that shares overlapping oncology membership and education missions with SBOC. It is the most direct Brazilian competitor in the oncology society space.
• IASLC (International Association for the Study of Lung Cancer): IASLC is a global specialty society focused on thoracic oncology. SBOC maintains a core institutional partnership with IASLC for lung cancer research and guidelines, making it a focused thematic peer within the broader oncology society landscape.

Broad incumbents

• ASTRO (American Society for Radiation Oncology): ASTRO is the leading U.S. radiation oncology society. It is a broad incumbent peer to SBOC given the multidisciplinary oncology society model (congress, guidelines, education, certification) and the international radiation oncology community.
• ASCO (American Society of Clinical Oncology): ASCO is the global benchmark professional society for clinical oncology, offering education (ASCO University), certification, guidelines, and a major annual meeting. SBOC is a direct institutional partner and Latin American counterpart, and serves as Brazil's ASCO-equivalent in scope and mission.
• ESMO (European Society for Medical Oncology): ESMO is the leading European clinical oncology society, with parallel offerings to SBOC: congress, educational programs, clinical guidelines, and the ESMO Summit Latin America hosted in partnership with SBOC. Highly comparable in mission and product set.

Regional players

• ABRALE (Associação Brasileira de Linfoma e Leucemia): ABRALE is a Brazilian patient-focused nonprofit addressing hematological cancers. It is a regional peer in the Brazilian oncology ecosystem with a different model (patient advocacy vs. physician society) but overlapping partners and policy focus areas.
• ABHH (Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular): ABHH is Brazil's national hematology society, a strategic partner of SBOC since 2025, with overlapping physician members in hemato-oncology. Comparable in structure (specialty society, congress, certification) and active partnership status.

Emerging players

• European Cancer Organisation (ECCO): ECCO is a European umbrella federation of oncology societies. It is comparable to SBOC as a multi-stakeholder oncology platform — but operates at a higher level of aggregation across societies, whereas SBOC is a single national specialty society.

Others

• INCA (Instituto Nacional de Câncer): INCA is Brazil's federal cancer institute and policy authority. SBOC participates in INCA's Consinca consultive council and collaborates on national cancer control programs. INCA is a peer in the Brazilian oncology ecosystem but operates as a government body rather than a member society.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sboc

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SBOC